Editorial commentary: Approach to the office patient with apparent resistant or refractory hypertension: Is there a role for renal denervation?
Author:
- 23 September 2024
- journal article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (2) , 105-106
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Controversies in Hypertension V: Resistant and Refractory HypertensionThe American Journal of Medicine, 2023
- Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUICHypertension, 2023
- A systematic review and meta-analysis of all sham and placebo controlled trials for resistant hypertensionEuropean Journal of Internal Medicine, 2023
- An Update on Refractory HypertensionCurrent Hypertension Reports, 2022
- Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart AssociationHypertension, 2018
- Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac VolumesHypertension, 2018
- Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurementJournal of the American Society of Hypertension, 2016
- Refractory HypertensionHypertension, 2015
- Prevalence of Optimal Treatment Regimens in Patients With Apparent Treatment-Resistant Hypertension Based on Office Blood Pressure in a Community-Based Practice NetworkHypertension, 2013
- Resistant HypertensionHypertension, 2002